The multiomics market in Thailand is expected to reach a projected revenue of US$ 51.8 million by 2033. A compound annual growth rate of 16.4% is expected of Thailand multiomics market from 2026 to 2033.
In terms of revenue, Thailand accounted for 0.5% of the global multiomics market in 2025.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In Asia Pacific, China multiomics market is projected to lead the regional market in terms of revenue in 2033.
India is the fastest growing regional market in Asia Pacific and is projected to reach USD 346.3 million by 2033.
Over the past few years, the multiomics market in Thailand has witnessed significant growth, primarily driven by an increasing focus on integrating genomics, proteomics, transcriptomics, and metabolomics to attain a comprehensive understanding of biological systems.
On the other hand, increasing investment in multiomics research by the Thai government has contributed to the overall market growth. In 2019, the Thai government introduced the Genomics Thailand Initiative to develop one of the most comprehensive medical databases in the region by cataloging the genomes of 50,000 Thai people till 2024.
Furthermore, genome sequencing technologies are becoming increasingly available in several Thailand institutes such as Thailand National Center for Genetic Engineering and Biotechnology (BIOTEC), Thailand Center of Excellence for Life Sciences (TCELS), and Ramathibodi Hospital’s Center for Medical Genomics, which further drives the overall market growth.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Multiomics Market Outlook will help companies and investors design strategic landscapes.
Bulk Multiomics was the largest segment with a revenue share of 76.13% in 2025.
Horizon Databook has segmented the Thailand multiomics market based on single-cell multiomics, bulk multiomics covering the revenue growth of each sub-segment from 2021 to 2033.
Over the past few years, the multiomics market in Thailand has witnessed significant growth, primarily driven by an increasing focus on integrating genomics, proteomics, transcriptomics, and metabolomics to attain a comprehensive understanding of biological systems.
On the other hand, increasing investment in multiomics research by the Thai government has contributed to the overall market growth. In 2019, the Thai government introduced the Genomics Thailand Initiative to develop one of the most comprehensive medical databases in the region by cataloging the genomes of 50,000 Thai people till 2024.
Furthermore, genome sequencing technologies are becoming increasingly available in several Thailand institutes such as Thailand National Center for Genetic Engineering and Biotechnology (BIOTEC), Thailand Center of Excellence for Life Sciences (TCELS), and Ramathibodi Hospital’s Center for Medical Genomics, which further drives the overall market growth.
Thailand Multiomics Market Type Outlook (Revenue, USD Million , 2021-2033)
Single-cell Multiomics
Bulk Multiomics
Thailand Multiomics Market Platform Outlook (Revenue, USD Million , 2021-2033)
Genomics
Transcriptomics
Proteomics
Metabolomics
Integrated Omics Platforms
Thailand Multiomics Market Product & Service Outlook (Revenue, USD Million , 2021-2033)
Services
Product
Thailand Multiomics Market End Use Outlook (Revenue, USD Million , 2021-2033)
Pharmaceutical & Biotechnology Companies
Others
Academic & Research Institutes
Thailand Multiomics Market Application Outlook (Revenue, USD Million , 2021-2033)
Immunology
Cell Biology
Oncology
Neurology
Reasons to subscribe to Multiomics Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Multiomics Market Outlook databook
Our clientele includes a mix of Multiomics Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Thailand Multiomics Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Thailand Multiomics Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.